Abrazo West Offers New Aquablation Therapy for Enlarged Prostate

Abrazo West Campus in Goodyear, Arizona, is the first hospital in the West Valley to offer Aquablation® therapy with the new HYDROS™ Robotic System, the next-generation platform to treat benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

“We are excited to offer this new therapy because it provides an effective, minimally invasive option to treat BPH and its related symptoms, while potentially preserving sexual function,” says Dr. Oliver S. Ko, urologist, Abrazo West Campus.

BPH is a non-cancerous condition where the prostate has grown to be larger than normal. The prevalence of BPH is estimated to be 50-75% in men age 50 and older, and upwards of 80% in men age 80 and older.It’s estimated that a quarter of all men will deal with symptoms related to this in their lifetime.

Aquablation therapy was designed to offer an effective solution for BPH, minimizing the need for men to choose between safety and efficacy. Aquablation therapy is unique in its use of real-time, ultrasound-guided, robotic-assisted waterjet technology, allowing surgeons to create a personalized treatment plan that precisely targets which prostate tissue to remove and which to preserve to safeguard critical anatomy.

Abrazo Health emphasizes the importance of men prioritizing their health and wellness by adopting healthy lifestyle choices, seeking regular medical check-ups and finding this type of advanced therapy if diagnosed with an enlarged prostate.

“This new HYDROS robotic system highlights another investment into advanced medical technology for the West Valley community,” says Hans Driessnack, CEO, Abrazo West Campus.